Clinical success with p53 gene therapy still a possibility

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1328, 2002-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanoparticle-mediated p53 gene therapy for tumor inhibition

By Sharma Blanka  

Drug Delivery and Translational Research, Vol. 1, Iss. 1, 2011-02 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite

Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy

By  

Current Medicinal Chemistry, Vol. 22, Iss. 35, 2015-11 ,pp. : 4118-4136

Bentham Science Publishers

Access to resources Recommend Favorite

p53 as the Focus of Gene Therapy: Past, Present and Future

By  

Current Drug Targets, Vol. 19, Iss. 15, 2018-12 ,pp. : 1801-1817

Bentham Science Publishers

Access to resources Recommend Favorite

Network Effect of Wt-mutant p53 Interactions and Implications on p53 Gene Therapy

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1259-1267

Bentham Science Publishers

Access to resources Recommend Favorite

INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, p53 Gene Therapy - Introgen, RPR/INGN 201

By Adis International Limited  

Drugs in R&D, Vol. 8, Iss. 3, 2007-01 ,pp. : 176-187

Adis International

Access to resources Recommend Favorite